1 Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, China.
2 Department of Bioengineering, Nagaoka University of Technology, Niigata, Japan.
J Neurotrauma. 2019 Feb 1;36(3):436-447. doi: 10.1089/neu.2018.5652. Epub 2018 Oct 10.
NB-3 (contactin-6) is a member of the contactin family and has a wide range of roles during central nervous system development and disease. Here, we found that NB-3 was simultaneously induced in the serotonergic raphespinal tract (sRST) axons and in the scar-forming cells after spinal cord injury (SCI). Regrowth of sRST axons was promoted in vivo by blocking NB-3 expression in either sRST axons or scar-forming cells when post-traumatic axons of the sRST tried to penetrate the glial scar. NB-3 deficiency promoted synapse reformation between sRST regenerative axons and motor neurons and enhanced the potential for electrical activity of muscle contraction and motor coordination. In vivo evidence also suggested that NB-3 induction in both sRST axons and scar-forming cells was required to mediate NB-3 signaling inhibition of sRST axon regeneration after SCI. Our findings suggest that NB-3 protein is a potential molecular target for future SCI treatments.
NB-3(接触蛋白-6)是接触蛋白家族的成员,在中枢神经系统发育和疾病中具有广泛的作用。在这里,我们发现 NB-3 同时在 5-羟色胺能中缝脊髓束(sRST)轴突和脊髓损伤(SCI)后的瘢痕形成细胞中被诱导。当 sRST 的创伤后轴突试图穿透神经胶质瘢痕时,通过在 sRST 轴突或瘢痕形成细胞中阻断 NB-3 表达,可以促进 sRST 轴突的体内再生。NB-3 缺乏促进了 sRST 再生轴突与运动神经元之间的突触形成,并增强了肌肉收缩和运动协调的电活动潜力。体内证据还表明,sRST 轴突和瘢痕形成细胞中 NB-3 的诱导是介导 SCI 后 NB-3 信号抑制 sRST 轴突再生所必需的。我们的研究结果表明,NB-3 蛋白是未来 SCI 治疗的潜在分子靶点。